Chapters in this book

1. Frontmatter I
2. Contributors V
3. Preface VII
4. Contents IX
5. Part I. Absorption And Metabolism of Long Chain and Medium Chain Triglycerides
6. 1. Introductory Remarks by the Chairman 3
7. 2. Intraluminal Factors in the Absorption of Glycerides 9
8. 3. Mechanisms of Absorption of Long and Medium Chain Triglycerides 21
9. 4. Discussion of Triglyceride Absorption 35
10. 5. Hepatic Metabolism of Medium Chain Fatty Acids 39
11. 6. Effects of Medium Chain Length Triglycerides on Serum Lipids 51
12. 7. Discussion of the Metabolic Fate of Medium Chain Triglycerides 63
13. Part II. Physiological and Clinical Studies with Medium Chain Triglycerides
14. 8. Limiting Factors in Maximal Steady State Absorption of Medium Chain Triglycerides 69
15. 9. Studies of Medium Chain Fatty Acid Transport in Portal Blood 81
16. 10. Discussion of Medium Chain Triglyceride and Fatty Acid Transport 91
17. 11. Studies of Medium Chain Triglycerides in Patients with Differing Mechanisms for Fat Malabsorption 97
18. 12. Effects of Graded Increments of Medium Chain Triglycerides on Nutrient Balance -in Subjects with Intestinal Resection 109
19. 13. Medium Chain Triglycerides in Adult Celiac Disease 121
20. 14. Discussion of Clinical Effects of Medium Chain Triglycerides in Some Intestinal Diseases 133
21. Part III. Clinical and Experimental Studies with Medium Chain Triglycerides
22. 15. Introductory Remarks by the Chairman 143
23. 16. Metabolic and Clinical Studies of Medium Chain Triglycerides in Subjects with Inflammatory Bowel Disease 145
24. 17. Medium Chain Triglycerides in the Treatment of Pancreatic Insufficiency and A-Betalipoproteinemia 155
25. 18. Replacement of Dietary Fat by Medium Chain Triglycerides in Cirrhotic Patients 165
26. 19. Discussion of Medium Chain Triglyceride Effects in Other Adult Diseases 173
27. 20. Some Considerations on the Therapeutic Use of Medium Chain Triglycerides in Patients with Malabsorption 185
28. 21. Panel Discussion of Practical Problems in Usage of Medium Chain Triglycerides 191
29. Part IV. Studies with Medium Chain Triglycerides in Infants and Children
30. 22. Introductory Remarks by the Chairman 205
31. 23. Medium Chain Triglycerides in Cystic Fibrosis 207
32. 24. The Value of Medium Chain Triglycerides in Malabsorptive Disorders in Childhood 219
33. 25. Discussion of the Pediatric Use of Medium Chain Triglycerides 237
34. 26. Summary Panel on Role of Medium Chain Triglycerides in Human Disease States and Possible Future Applications 247
35. References 263
36. Appendices 275
37. Index 287